The last day to benefit from early registration prices for ESCMID Global 2026 is tomorrow, 11 February. Remember that ESCMID members receive additional discounts as well so renew your ESCMID membership and get the best deal to attend the largest event in the field of infection.

Science & Research

Late-breaking abstract submission for ESCMID Global is closing this week on 13 February. Don’t miss the opportunity to add your original research to the scientific programme and share your findings with the community.

Education

Further your professional growth with the EUCIC Certificate programme specialising in infection prevention and control (IPC) and healthcare-associated infection (HAI) topics. Discover testimonials from past graduates and sign-up for the upcoming 2026-2028 cohort.

This interactive, onsite programme is tailored for healthcare professionals with experience in infection prevention and control – providing a comprehensive update on the evolving challenges of multidrug-resistant organisms (MDROs).

This course is part of the ESCMID EUCIC Certificate programme and has a few spots available for additional participants.

Congress & Events

Discover the key milestones of BK virus research from its discovery to our current understanding of the disease with this keynote lecture from Hans Hirsch. You can read more about him and his talk on our website – and be sure to attend the lecture during ESCMID Global 2026.

Register today to attend the 21st International Congress on Infectious Diseases 2026, hosted by the International Society for Infectious Diseases (ISID) taking place in Madrid, Spain from 10-13 November 2026. And be sure to submit your abstracts to be included in the cutting-edge scientific programme. Learn more and get involved!

Abstract submission deadline: 28 April 2026

Early bird registration deadline: 30 July 2026

Guidelines & Journals

In this episode, Navaneeth Narayanan and Josh Nosanchuk invite Virginie Lemiale and Elie Azoulay as well as fellow editor Emily McDonald to discuss adjunctive steroid therapy for pneumocystis pneumonia (PCP) in HIV-negative individuals.

In this week’s Epi Alert you can find updates on an accelerating chikungunya outbreak in Suriname and Seychelles resulting in a travel health notice from the CDC. Measles was reported in 30 countries with over 7.6K cases in 2025 across Europe, with a current outbreak in France. Finally, learn more about Bacillus cereus toxin (cereulide) being found in infant formula in Europe resulting in a multi-country recall as investigations continue.

A Phase Ib, Placebo-controlled Randomized Clinical Trial of the Ebolavirus DNA Vaccine Candidate INO-4201 Followed by Electroporation as Booster Vaccination in Healthy, rVSVΔG-ZEBOV-GP-primed Volunteers (Boost-EBOV)

Reframing Success: Lessons on Non-inferiority Trials from GAME CHANGER

European Commission is organising a high-level conference on Medical Devices and IVDs in Brussels on 16 March 2026 (09:00-17:00 CET).

Apply to be considered for inclusion in the expert panels for medical devices which will be renewed in August 2026.